Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure

Journal of Immunology

Volumn 184, Issue 1, 2010, Pages 466-475

  Zou, Yong ^a   Chen, Tao ^a   Han, Meifang ^a   Wang, Hongwu ^a   Yan, Weiming ^a   Song, Ge ^a   Wu, Zeguang ^a   Wang, Xiaojing ^a   Zhu, Chuanlong ^c   Luo, Xiaoping ^b   Ning, Qin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; MONOCLONAL ANTIBODY; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D; TUMOR NECROSIS FACTOR ALPHA;

ACUTE ON CHRONIC LIVER FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL ACTIVATION; CELL COUNT; CELL FUNCTION; CELL KILLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE COURSE; FEMALE; FULMINANT HEPATIC FAILURE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER CELL DAMAGE; LIVER FAILURE; LIVER NECROSIS; MALE; MOUSE; MURINE HEPATITIS CORONAVIRUS; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; SURVIVAL; UPREGULATION; VIRUS INFECTION; ADULT; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; FLOW CYTOMETRY; IMMUNOLOGY; NECROSIS; PATHOLOGY; VIROLOGY; VIRUS HEPATITIS;

ADULT; ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HEPATITIS, VIRAL, HUMAN; HEPATOCYTES; HUMANS; KILLER CELLS, NATURAL; LIVER FAILURE; MALE; MICE; MICE, INBRED BALB C; NECROSIS; YOUNG ADULT;

EID: 73949112938     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900687     Document Type: Article

References (35)

1. Marsden, P. A., Q. Ning, L. S. Fung, X. Luo, Y. Chen, M. Mendicino, A. Ghanekar, J. A. Scott, T. Miller, C. W. Chan, et al. 2003. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J. Clin. Invest. 112: 58-66.
2. Liu, M., C. W. Chan, I. McGilvray, Q. Ning, and G. A. Levy. 2001. Fulminant viral hepatitis: molecular and cellular basis, and clinical implications. Expert Rev. Mol. Med. 2001: 1-19.
3. Sarin, S. K., A. Kumar, J. A. Almeida, Y. K. Chawla, S. T. Fan, H. Garg, H. J. de Silva, S. S. Hamid, R. Jalan, P. Komolmit, et al. 2009. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol. Int. 3: 269-282.
4. Liu, Q., Z. Liu, T. Wang, Q. Wang, X. Shi, and W. Dao. 2007. Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval. J. Gastroenterol. Hepatol. 22: 2101-2106.
5. Custer, B., S. D. Sullivan, T. K. Hazlet, U. Iloeje, D. L. Veenstra, and K. V. Kowdley. 2004. Global epidemiology of hepatitis B virus. J. Clin. Gastroenterol. 38(10):, Suppl 3)S158-S168.
6. Ando, K., T. Moriyama, L. G. Guidotti, S. Wirth, R. D. Schreiber, H. J. Schlicht, S. N. Huang, and F. V. Chisari. 1993. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178: 1541-1554.
7. Guidotti, L. G., K. Ando, M. V. Hobbs, T. Ishikawa, L. Runkel, R. D. Schreiber, and F. V. Chisari. 1994. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA 91: 3764-3768.
8. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220.
9. Guidotti, L. G., and F. V. Chisari. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19: 65-91.
10. Ferlazzo, G., M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman, and C. Münz. 2002. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195: 343-351.
11. Zingoni, A., T. Sornasse, B. G. Cocks, Y. Tanaka, A. Santoni, and L. L. Lanier. 2004. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J. Immunol. 173: 3716-3724. (Pubitemid 39280732)
12. Mackay, I. R. 2002. Hepatoimmunology: a perspective. Immunol. Cell Biol. 80: 36-44.
13. Norris, S., C. Collins, D. G. Doherty, F. Smith, G. McEntee, O. Traynor, N. Nolan, J. Hegarty, and C. O'Farrelly. 1998. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J. Hepatol. 28: 84-90.
14. Ochi, M., H. Ohdan, H. Mitsuta, T. Onoe, D. Tokita, H. Hara, K. Ishiyama, W. Zhou, Y. Tanaka, and T. Asahara. 2004. Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice. Hepatology 39: 1321-1331.
15. Chen, Y., H. Wei, R. Sun, Z. Dong, J. Zhang, and Z. Tian. 2007. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology 46: 706-715.
16. Seeger, C., and W. S. Mason. 2000. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64: 51-68.
17. Jung, M. C., and G. R. Pape. 2002. Immunology of hepatitis B infection. Lancet Infect. Dis. 2: 43-50.
18. Ichiki, Y., X. S. He, S. Shimoda, H. Ishibashi, E. B. Keeffe, L. Rossaro, and M. E. Gershwin. 2005. T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity. Autoimmun. Rev. 4: 82-95.
19. Hui, C. K., and G. K. Lau. 2005. Immune system and hepatitis B virus infection. J. Clin. Virol. 34(Suppl 1): S44-S48.
20. Dunn, C., M. Brunetto, G. Reynolds, T. Christophides, P. T. Kennedy, P. Lampertico, A. Das, A. R. Lopes, P. Borrow, K. Williams, et al. 2007. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J. Exp. Med. 204: 667-680.
21. Jolicoeur, P., and L. Lamontagne. 1994. Impaired T and B cell subpopulations involved in a chronic disease induced by mouse hepatitis virus type 3. J. Immunol. 153: 1318-7. (Pubitemid 24228524)
22. Lehoux, M., A. Jacques, S. Lusignan, and L. Lamontagne. 2004. Murine viral hepatitis involves NK cell depletion associated with virus-induced apoptosis. Clin. Exp. Immunol. 137: 41-51.
23. Liu, M., M. Mendicino, Q. Ning, A. Ghanekar, W. He, I. McGilvray, I. Shalev, D. Pivato, D. A. Clark, M. J. Phillips, and G. A. Levy. 2006. Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite cis elements. J. Immunol. 176: 7028-7038.
24. Ning, Q., D. Brown, J. Parodo, M. Cattral, R. Gorczynski, E. Cole, L. Fung, J. W. Ding, M. F. Liu, O. Rotstein, et al. 1998. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J. Immunol. 160: 3487-3493.
25. Zhu, C. L., W. M. Yan, F. Zhu, Y. F. Zhu, D. Xi, D. Y. Tian, G. Levy, X. P. Luo, and Q. Ning. 2005. Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B. World J. Gastroenterol. 11: 6936-6940.
26. Han, M., W. Yan, W. Guo, D. Xi, Y. Zhou, W. Li, S. Gao, M. Liu, G. Levy, X. Luo, and Q. Ning. 2008. Hepatitis B virus-induced hFGL2 transcription is dependent on c-Ets-2 and MAPK signal pathway. J. Biol. Chem. 283: 32715-32729.
27. Rukavina, D., G. Laskarin, G. Rubesa, N. Strbo, I. Bedenicki, D. Manestar, M. Glavas, S. E. Christmas, and E. R. Podack. 1998. Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells. Blood 92: 2410-2420.
28. Fehniger, T. A., S. F. Cai, X. Cao, A. J. Bredemeyer, R. M. Presti, A. R. French, and T. J. Ley. 2007. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26: 798-811.
29. Bukowski, J. F., B. A. Woda, S. Habu, K. Okumura, and R. M. Welsh. 1983. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 131: 1531-1538.
30. Mavilio, D., J. Benjamin, M. Daucher, G. Lombardo, S. Kottilil, M. A. Planta, E. Marcenaro, C. Bottino, L. Moretta, A. Moretta, and A. S. Fauci. 2003. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc. Natl. Acad. Sci. USA 100: 15011-15016.
31. Nattermann, J., G. Feldmann, G. Ahlenstiel, B. Langhans, T. Sauerbruch, and U. Spengler. 2006. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 55: 869-877.
32. De Maria, A., M. Fogli, S. Mazza, M. Basso, A. Picciotto, P. Costa, S. Congia, M. C. Mingari, and L. Moretta. 2007. Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur. J. Immunol. 37: 445-455.
33. Vilarinho, S., K. Ogasawara, S. Nishimura, L. L. Lanier, and J. L. Baron. 2007. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc. Natl. Acad. Sci. USA 104: 18187-18192.
34. Tokushige, K., K. Hasegawa, K. Yamauchi, and N. Hayashi. 2002. Analysis of natural killer cells and interleukin-15 in patients with acute and fulminant hepatitis. Hepatol. Res. 23: 31-37.
35. Morsica, G., S. Tasca, P. Biswas, A. Galli, M. Malnati, C. Paties, M. Marinelli, S. Bagaglio, A. Lazzarin, and C. Fortis. 2005. Natural killer-cell cytotoxicity in HIV-positive and HIV-negative patients with and without severe course of hepatitis B virus infection. Scand. J. Immunol. 62: 318-324.